The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2. [electronic resource]
Producer: 20130927Description: 237-47 p. digitalISSN:- 1872-7980
- Animals
- Antineoplastic Agents -- immunology
- Antineoplastic Agents, Alkylating -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Atrophy
- B7-2 Antigen -- metabolism
- Cyclophosphamide -- pharmacology
- Drug Synergism
- Histocompatibility Antigens Class I -- metabolism
- Hydrocortisone -- pharmacology
- Immunologic Factors -- metabolism
- Immunosuppressive Agents -- pharmacology
- Interferon-gamma -- blood
- Male
- Melanoma, Experimental -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Protein Binding
- Skin Neoplasms -- drug therapy
- Surface Plasmon Resonance
- Thymalfasin
- Thymocytes -- drug effects
- Thymopentin -- immunology
- Thymosin -- analogs & derivatives
- Thymus Gland -- drug effects
- Time Factors
- Toll-Like Receptor 2 -- metabolism
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.